References: Intermittent vancomycin dosing in young infants and children

  • Alobaid AS, Hites M, Lipman J, Taccone FS, Roberts JA. Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review. Int J Antimicrob Agents 2016;47(4):259-68. https://www.ncbi.nlm.nih.gov/pubmed/26988339
  • Demirjian A, Finkelstein Y, Nava-Ocampo A, Arnold A, Jones S, Monuteaux M, et al. A randomized controlled trial of a vancomycin loading dose in children. Pediatr Infect Dis J 2013;32(11):1217-23. https://www.ncbi.nlm.nih.gov/pubmed/23817340
  • Dolan E, Hellinga R, London M, Ryan K, Dehority W. Effect of Vancomycin Loading Doses on the Attainment of Target Trough Concentrations in Hospitalized Children. J Pediatr Pharmacol Ther 2020;25(5):423-30. https://www.ncbi.nlm.nih.gov/pubmed/32641912
  • Gwee A, Cranswick N, McMullan B, Perkins E, Bolisetty S, Gardiner K, et al. Continuous Versus Intermittent Vancomycin Infusions in Infants: A Randomized Controlled Trial. Pediatrics 2019;143(2). https://www.ncbi.nlm.nih.gov/pubmed/30700564
  • Hill LF, Clements MN, Turner MA, Dona D, Lutsar I, Jacqz-Aigrain E, et al. Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial. Lancet Child Adolesc Health 2022;6(1):49-59. https://www.ncbi.nlm.nih.gov/pubmed/34843669
  • Khare M, Azim A, Kneese G, Haag M, Weinstein K, Rhee KE, et al. Vancomycin Dosing in Children With Overweight or Obesity: A Systematic Review and Meta-analysis. Hosp Pediatr 2020;10(4):359-68. https://www.ncbi.nlm.nih.gov/pubmed/32213528
  • Le J, Capparelli EV, Wahid U, Wu YS, Romanowski GL, Tran TM, et al. Bayesian Estimation of Vancomycin Pharmacokinetics in Obese Children: Matched Case-Control Study. Clin Ther 2015;37(6):1340-51. https://www.ncbi.nlm.nih.gov/pubmed/26031618